PMV Pharmaceuticals director awarded 42,000 stock options
PMV Pharmaceuticals director Charles M. Baum received a grant of stock options covering 42,000 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
PMV Pharmaceuticals director Charles M. Baum received a grant of stock options covering 42,000 shares of common stock. The options have an exercise price of $1.19 per share and expire on June 4, 2036. They vest on the earlier of June 4, 2027 or the company’s next annual stockholder meeting. Following this award, Baum holds 42,000 stock options directly.
Insider Trade Summary
Grant/Award: 42,000 shares
Grant/Award
1 txn
Insider
BAUM CHARLES M
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 42,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 42,000 contracts (Direct)
Footnotes (1)
- F1. Shares subject to the option vest on the earlier of (i) June 4, 2027 or (ii) the date of the Issuer's next annual meeting of stockholders.
Key Figures
Options granted: 42,000 options
Exercise price: $1.19 per share
Expiration date: June 4, 2036
+2 more
5 metrics
Options granted
42,000 options
Stock Option (right to buy) grant to director
Exercise price
$1.19 per share
Conversion or exercise price of options
Expiration date
June 4, 2036
Option expiration date
Underlying shares
42,000 shares
Common stock underlying the options
Post-grant option holdings
42,000 options
Total derivative shares following transaction
Key Terms
Stock Option (right to buy), Grant, award, or other acquisition, exercise price, vesting, +1 more
5 terms
Stock Option (right to buy) financial
"security_title: Stock Option (right to buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
exercise price financial
"conversion_or_exercise_price: 1.1900"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"Shares subject to the option vest on the earlier of June 4, 2027 or next annual meeting"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date: 2036-06-04T00:00:00.000Z"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PMV Pharmaceuticals (PMVP) disclose about Charles M. Baum in this filing?
PMV Pharmaceuticals reported that director Charles M. Baum received a grant of stock options for 42,000 shares. These options are a form of equity compensation, giving him the right to buy common stock at a fixed price in the future.
How many stock options did Charles M. Baum receive from PMV Pharmaceuticals (PMVP)?
Charles M. Baum received stock options covering 42,000 shares of PMV Pharmaceuticals common stock. This award increases his potential future ownership if he later exercises the options at the specified exercise price.
What is the exercise price of Charles M. Baum’s PMV Pharmaceuticals (PMVP) stock options?
The stock options granted to Charles M. Baum have an exercise price of $1.19 per share. This means he can buy PMV Pharmaceuticals common stock at $1.19 per share if and when the options are exercised after vesting.
When do Charles M. Baum’s PMV Pharmaceuticals (PMVP) stock options vest?
The options vest on the earlier of June 4, 2027, or the date of PMV Pharmaceuticals’ next annual stockholder meeting. Vesting determines when Baum can begin exercising the options to purchase common shares.
When do the newly granted PMV Pharmaceuticals (PMVP) stock options expire?
The stock options granted to Charles M. Baum expire on June 4, 2036. After that expiration date, he can no longer use these options to buy PMV Pharmaceuticals common stock, even if they were previously vested.
How many PMV Pharmaceuticals (PMVP) options does Charles M. Baum hold after this grant?
Following this grant, Charles M. Baum holds 42,000 stock options directly. This figure represents his position in this specific option award as reported, giving him potential future rights to purchase common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
